[Form 3] Nano-X Imaging Ltd. Initial Statement of Beneficial Ownership
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Nano-X Imaging Ltd. Chief Legal Officer Marina Gofman Feler filed an initial ownership report on 2026-03-18. She holds stock options over 15,000 ordinary shares at an exercise price of 17.6300 expiring on 2032-11-07, options over 10,000 shares at 17.6300 expiring on 2033-04-28, and options over 30,000 shares at 11.5200 expiring on 2033-05-23.
She also holds 20,000 ordinary shares underlying restricted share units granted on 2026-02-05, which vest 50% on the 12-month anniversary of the grant date and 50% on the 24-month anniversary. A separate line shows 26,316 additional ordinary shares held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Gofman Feler Marina
Role
Chief Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
| holding | Ordinary shares | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy ordinary shares) — 15,000 shares (Direct);
Ordinary shares — 20,000 shares (Direct)
Footnotes (1)
- The ordinary shares reported in this row consist of shares underlying restricted share units that were granted to the Reporting Person on February 5, 2026 and of which 50% will vest on the 12-month anniversary of the grant date and the remaining 50% will vest upon the 24-month anniversary of the grant date. The options reported in this row were granted to the Reporting Person by the Issuer on November 7, 2022 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that grant date (November 7, 2026). The options reported in this row were granted to the Reporting Person by the Issuer on April 28, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that grant date (April 28, 2027). The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable on the four-year anniversary of that appointment date (May 23, 2027).
FAQ
What does the Nano-X Imaging (NNOX) Form 3 filing show for Marina Gofman Feler?
The Form 3 shows Marina Gofman Feler’s initial ownership as Chief Legal Officer, including stock options over 55,000 ordinary shares and direct holdings of ordinary shares and restricted share units with defined vesting and expiration schedules.
How many Nano-X Imaging (NNOX) stock options does the CLO hold and at what prices?
She holds options linked to 15,000 and 10,000 ordinary shares at an exercise price of $17.6300, and options linked to 30,000 ordinary shares at $11.5200, each with separate expiration dates in 2032 and 2033.
When do Marina Gofman Feler’s Nano-X Imaging (NNOX) stock options expire?
The options expire on 2032-11-07 for 15,000 underlying shares, 2033-04-28 for 10,000 underlying shares, and 2033-05-23 for 30,000 underlying shares, assuming they vest and are not exercised earlier.